Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)
28,600
+800 (2.88%)
Feb 21, 2025, 3:30 PM KST
Mezzion Pharma Revenue
Mezzion Pharma had revenue of 2.26B KRW in the quarter ending September 30, 2024, a decrease of -73.18%. This brings the company's revenue in the last twelve months to 14.08B, down -56.15% year-over-year. In the year 2023, Mezzion Pharma had annual revenue of 31.72B with 3.24% growth.
Revenue (ttm)
14.08B
Revenue Growth
-56.15%
P/S Ratio
60.51
Revenue / Employee
828.05M
Employees
17
Market Cap
856.95B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 31.72B | 994.76M | 3.24% |
Dec 31, 2022 | 30.73B | 4.07B | 15.28% |
Dec 31, 2021 | 26.65B | -1.98B | -6.92% |
Dec 31, 2020 | 28.63B | 10.71B | 59.79% |
Dec 31, 2019 | 17.92B | -1.17B | -6.11% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2012 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 300.87T |
SK hynix | 57.73T |
LG Energy Solution | 25.62T |
Samsung Biologics | 4,364.39B |
Hyundai Motor Company | 170.28T |
Celltrion | 2,876.25B |
Kia Corporation | 104.63T |
NAVER | 10.39T |